The Metastatic Cancer Treatment Market is highly segmented, primarily based on the therapeutic mechanism of action, leading to three major segments: targeted therapies (e.g., small molecule inhibitors, monoclonal antibodies), immunotherapies (e.g., checkpoint inhibitors, cell therapies), and traditional cytotoxics/hormone therapies. The immunotherapy segment, which includes cutting-edge...